Home › Companies › TRANSMEDICS GROUP INC. › 2023-2024

TRANSMEDICS GROUP INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TRANSMEDICS GROUP INC.’s Form 8-K, filed May 28, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 10Ballot items
  • 280Asset managers
  • 2,832Fund votes
  • May 23, 2024Meeting date

Results at a glance

Meeting of May 23, 2024: 10 items on TRANSMEDICS GROUP INC.’s Form 8-K, filed May 28, 2024: 8 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TRANSMEDICS GROUP INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TRANSMEDICS GROUP INC.

These tallies are TRANSMEDICS GROUP INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TRANSMEDICS GROUP INC. — official shareholder meeting results, meeting held May 23, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Waleed Hassanein, M.D 24,024,298208,9477,690 --2,988,846 99.1%Elected—
Elect Director: James R. Tobin 23,518,088711,23911,608 --2,988,846 97%Elected—
Elect Director: Edward M. Basile 19,849,6034,379,66411,668 --2,988,846 82%Elected—
Elect Director: Thomas J. Gunderson 23,873,171356,02311,741 --2,988,846 99%Elected—
Elect Director: Edwin M. Kania, Jr. 23,550,271679,02311,641 --2,988,846 97%Elected—
Elect Director: Stephanie Lovell 23,789,019441,90510,011 --2,988,846 98%Elected—
Elect Director: Merilee Raines 23,928,824302,04010,071 --2,988,846 99%Elected—
Elect Director: David Weill, M.D. 23,735,272494,17511,488 --2,988,846 98%Elected—
2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes 22,902,3591,321,62716,949 --2,988,846 95%Approved—
3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024, based on the following votes 26,468,778748,89012,113 ---- 97%Approved—

This meeting is also recorded here as May 24, 2024; both records come from the same filing, so the date should be checked against it.

Source: TRANSMEDICS GROUP INC., Form 8-K, filed with the SEC on May 28, 2024 — read the filing on EDGAR.

How asset managers voted at the TRANSMEDICS GROUP INC. 2023-2024 meeting

Each item below shows how the 280 asset managers that disclosed a TRANSMEDICS GROUP INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Waleed Hassanein, M.D

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 24,024,298AGAINST: 208,947
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: Waleed Hassanein, M.D.

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Waleed Hassanein, M.D”): 24,024,298 for, 208,947 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: Waleed Hassanein, M.D.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price220,3500 00For
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4140 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,364,817 for, 2 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: Waleed Hassanein, M.D.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

2. Elect Director: James R. Tobin

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 23,518,088AGAINST: 711,239
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: James R. Tobin

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: James R. Tobin”): 23,518,088 for, 711,239 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: James R. Tobin” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,143,476 for, 221,412 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: James R. Tobin” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

3. Elect Director: Edward M. Basile

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST
FOR: 19,849,603AGAINST: 4,379,664
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: Edward M. Basile

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edward M. Basile”): 19,849,603 for, 4,379,664 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: Edward M. Basile” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,936,60821,632 00For
Vanguard1,794,429515,648 00Mixed
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie0828,083 00Against
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed0194,400 00Against
Brighthouse191,4131 00For
MERIDIAN FUND INC0171,714 00Against
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle0104,021 00Against
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 12,165,233 for, 2,199,690 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: Edward M. Basile” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

4. Elect Director: Thomas J. Gunderson

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 23,873,171AGAINST: 356,023
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: Thomas J. Gunderson

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Thomas J. Gunderson”): 23,873,171 for, 356,023 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: Thomas J. Gunderson” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,144,307 for, 220,530 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: Thomas J. Gunderson” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

5. Elect Director: Edwin M. Kania, Jr.

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 23,550,271AGAINST: 679,023
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: Edwin M. Kania, Jr.

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edwin M. Kania, Jr.”): 23,550,271 for, 679,023 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,143,568 for, 221,337 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

6. Elect Director: Stephanie Lovell

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,789,019AGAINST: 441,905
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: Stephanie Lovell

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Stephanie Lovell”): 23,789,019 for, 441,905 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: Stephanie Lovell” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,143,628 for, 221,225 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: Stephanie Lovell” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

7. Elect Director: Merilee Raines

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 23,928,824AGAINST: 302,040
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: Merilee Raines

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Merilee Raines”): 23,928,824 for, 302,040 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: Merilee Raines” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,144,341 for, 220,530 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: Merilee Raines” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

8. Elect Director: David Weill, M.D.

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 23,735,272AGAINST: 494,175
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Directors: David Weill, M.D.

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: David Weill, M.D.”): 23,735,272 for, 494,175 against, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “Election of Directors: David Weill, M.D.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price0220,350 00Against
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4131 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,143,714 for, 221,225 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “Election of Directors: David Weill, M.D.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,894,9610 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,895,518 for.

9. 2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 17 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 22,902,359AGAINST: 1,321,627
Details: description as filed, official tally, votes by 277 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

TRANSMEDICS GROUP INC.’s own tally for this item (“2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes”): 22,902,359 for, 1,321,627 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 81 asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price220,3500 00For
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4140 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 81 managers: 14,369,093 for, 13,508 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 217 asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity4,058,408156,998 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST1,181,3780 00For
ArrowMark Colorado Holdings LLC886,8410 00For
Invesco838,8830 00For
DRIEHAUS CAPITAL MANAGEMENT LLC809,9870 00For
BlackRock735,4390 00For
UBS0694,478 00Against
First Light Asset Management, LLC673,0680 00For
MACKENZIE FINANCIAL CORP666,2860 00For
State Street538,4430 00For
Allspring536,9080 00For
LORD, ABBETT & CO. LLC457,3270 00For
EMERALD MUTUAL FUND ADVISERS TRUST370,0140 00For
GEODE CAPITAL MANAGEMENT, LLC349,3180 00For
WASATCH ADVISORS LP307,2630 00For
Eagle Health Investments LP278,6550 00For
FULLER & THALER ASSET MANAGEMENT, INC.264,5590 00For
Charles Schwab257,3240 00For
T. Rowe Price250,6990 00For
EMERALD ADVISERS, LLC217,4790 00For
NEXT CENTURY GROWTH INVESTORS LLC216,4150 00For
BAILLIE GIFFORD & CO LTD207,0480 00For
OBERWEIS ASSET MANAGEMENT INC/198,2000 00For
BRAIDWELL LP191,5520 00For
Northern Trust173,55222 00For

Institutional-manager reports, all 217 managers: 16,872,330 for, 1,075,754 against, 20 withheld, 2,118 abstained, 1,883 not voted. Showing the 25 largest; see all in the interactive database.

10. 3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its…

Official resultFund totals may overlapAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 26,468,778AGAINST: 748,890
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024.

TRANSMEDICS GROUP INC.’s own tally for this item (“3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024, based on the following votes”): 26,468,778 for, 748,890 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three : The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024, based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 80 asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity3,958,2400 00For
Vanguard2,310,0770 00For
MUTUAL FUND SERIES TRUST1,174,2020 00For
Delaware/Macquarie828,0830 00For
Invesco790,4100 00For
BlackRock589,2140 00For
Allspring425,4700 00For
Lord Abbett358,6790 00For
Royce315,1980 00For
WASATCH FUNDS TRUST267,6280 00For
Charles Schwab257,3240 00For
Bridge Builder Trust236,8210 00For
FINANCIAL INVESTORS TRUST222,4810 00For
T. Rowe Price220,3500 00For
OBERWEIS FUNDS198,2000 00For
Waddell & Reed194,4000 00For
Brighthouse191,4140 00For
MERIDIAN FUND INC171,7140 00For
DRIEHAUS MUTUAL FUNDS171,3800 00For
Capitol Series Trust170,4000 00For
Principal148,7530 00For
Columbia Threadneedle104,0210 00For
Equitable93,4000 00For
BUFFALO FUNDS91,2910 00For
Jackson National84,1240 00For

Fund voting reports, all 80 managers: 14,363,468 for, 1,318 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TRANSMEDICS GROUP INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP3,415,9000 00For
Keel Point, LLC5570 00For

Institutional-manager reports, all 2 managers: 3,416,457 for.

Largest TRANSMEDICS GROUP INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,851,376 shares outstanding at the time of that meeting.

Fund voting reports: top TRANSMEDICS GROUP INC. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 12.05%
2Vanguard 7.03%
3MUTUAL FUND SERIES TRUST 3.57%
4Delaware/Macquarie 2.52%
5Invesco 2.41%
6BlackRock 1.79%
7Allspring 1.30%
8Lord Abbett 1.09%
9Royce 0.96%
10WASATCH FUNDS TRUST 0.81%
Institutional-manager reports: top TRANSMEDICS GROUP INC. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 12.83%
2MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 3.60%
3ArrowMark Colorado Holdings LLC 2.70%
4Invesco 2.55%
5DRIEHAUS CAPITAL MANAGEMENT LLC 2.47%
6BlackRock 2.24%
7UBS 2.11%
8First Light Asset Management, LLC 2.05%
9MACKENZIE FINANCIAL CORP 2.03%
10State Street 1.64%

Reported TRANSMEDICS GROUP INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

TRANSMEDICS GROUP INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 16.23% 13F
FMR (Fidelity) 15.42% 13F
FMR LLC 14.94% DEF14A
Vanguard Group 10.98% 13F
Waleed Hassanein, M.D. 4.14% DEF14A
Invesco 3.90% 13F
State Street 2.36% 13F
Goldman Sachs 2.32% 13F
Geode Capital 2.20% 13F
Morgan Stanley 1.67% 13F

Percentages above are of 32,851,376 shares outstanding, as reported by TRANSMEDICS GROUP INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TRANSMEDICS GROUP INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At TRANSMEDICS GROUP INC.'s shareholder meeting held May 23, 2024, in the 2023-2024 proxy season, 280 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 2,832 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named… — TRANSMEDICS GROUP INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: TRANSMEDICS GROUP INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 28, 2024.

TRANSMEDICS GROUP INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.